Complejo Hospitalario Universitario de Vigo
Centro asistencial
National University of Ireland, Galway
Galway, IrlandaPublicaciones en colaboración con investigadores/as de National University of Ireland, Galway (26)
2024
-
Impact of the COVID-19 Pandemic on Global TAVR Activity: The COVID-TAVI Study
JACC: Cardiovascular Interventions, Vol. 17, Núm. 3, pp. 374-387
-
Ten-year prognostic impact of target versus non-target vessel failure after STEMI. Insight from the EXAMINATION-EXTEND trial
Revista Espanola de Cardiologia, Vol. 77, Núm. 3, pp. 215-225
2023
-
Impact of Age at the Time of the First ST-Elevation Myocardial Infarction on 10-Year Outcomes (from the EXAMINATION-EXTEND Trial)
American Journal of Cardiology, Vol. 190, pp. 32-40
-
Relationship between stent length and very long-term target lesion failure following percutaneous coronary intervention for ST-elevation myocardial infarction in the drug-eluting stents era: insights from the EXAMINATION-EXTEND study
American Heart Journal, Vol. 264, pp. 72-82
2022
-
Abbreviated Antiplatelet Therapy After Coronary Stenting in Patients With Myocardial Infarction at High Bleeding Risk
Journal of the American College of Cardiology, Vol. 80, Núm. 13, pp. 1220-1237
-
Angiography-derived physiology guidance vs usual care in an All-comers PCI population treated with the healing-targeted supreme stent and Ticagrelor monotherapy: PIONEER IV trial design
American Heart Journal, Vol. 246, pp. 32-43
-
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: Final results of the SYNTAX II study
European Heart Journal, Vol. 43, Núm. 13, pp. 1307-1316
-
Impact of Diabetes on 10-Year Outcomes Following ST-Segment–Elevation Myocardial Infarction: Insights From the EXAMINATION-EXTEND Trial
Journal of the American Heart Association, Vol. 11, Núm. 23
-
Sex Differences in 10-Year Outcomes Following STEMI: A Subanalysis From the EXAMINATION-EXTEND Trial
JACC: Cardiovascular Interventions, Vol. 15, Núm. 19, pp. 1965-1973
-
Validation of the OAKS prognostic model for acute kidney injury after gastrointestinal surgery
BJS Open, Vol. 6, Núm. 1
2021
-
10-Year Follow-Up of Patients With Everolimus-Eluting Versus Bare-Metal Stents After ST-Segment Elevation Myocardial Infarction
Journal of the American College of Cardiology, Vol. 77, Núm. 9, pp. 1165-1178
-
Abbreviated Antiplatelet Therapy in Patients at High Bleeding Risk With or Without Oral Anticoagulant Therapy After Coronary Stenting: An Open-Label, Randomized, Controlled Trial
Circulation, Vol. 144, Núm. 15, pp. 1196-1211
-
Breast cancer risk genes - Association analysis in more than 113,000 women
New England Journal of Medicine, Vol. 384, Núm. 5, pp. 428-439
-
Dual antiplatelet therapy after PCI in patients at high bleeding risk
New England Journal of Medicine, Vol. 385, Núm. 18, pp. 1643-1655
-
Unplanned Percutaneous Coronary Revascularization After TAVR: A Multicenter International Registry
JACC: Cardiovascular Interventions, Vol. 14, Núm. 2, pp. 198-207
2020
-
Association of diabetes with outcomes in patients undergoing contemporary percutaneous coronary intervention: Pre-specified subgroup analysis from the randomized GLOBAL LEADERS study
Atherosclerosis, Vol. 295, pp. 45-53
-
Bioresorbable scaffolds versus everolimus-eluting metallic stents: Five-year clinical outcomes of the randomised ABSORB II trial
EuroIntervention, Vol. 16, Núm. 11, pp. E938-E941
-
Comparison of long-term clinical outcomes in multivessel coronary artery disease patients treated either with bioresoarbable polymer sirolimus-eluting stent or permanent polymer everolimus-eluting stent: 5-year results of the CENTURY II randomized clinical trial
Catheterization and Cardiovascular Interventions, Vol. 95, Núm. 2, pp. 175-184
-
Endothelial shear stress and vascular remodeling in bioresorbable scaffold and metallic stent
Atherosclerosis, Vol. 312, pp. 79-89
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73